Notably, a prior study by Zou et al.20reported that enriched CD8+ tumor‐infiltration T cells, quantified by using a DNA methylation‐based method, was associated with MSI‐H tumors in CRC cohorts and predicted better survival. The gene discussed is CD8A; the disease is colorectal carcinoma.